Millions of people suffer and die from diseases that disproportionately affect the poor. These include malaria and tuberculosis as well as a long list of other tropical diseases such as onchocerciasis and lymphatic filariasis. The Bill & Melinda Gates foundation (BMGF) is driven by the belief that every life has equal value. Providing the tools to improve the health of the poorest is a critical aspect of our work and this includes the discovery and development of drugs which will have the most impact on the lives of the poor. Often pharmaceutical companies cannot easily justify the significant investments needed to discover and develop drugs for these diseases. This is where the BMGF can step in and help to build partnerships and provide funding to de-risk drug discovery and development projects. The BMGF works with Product Development Partners including Medicines for Malaria Venture, The TB Alliance and Drugs for Neglected Diseases Initiative to harness the best academic research and couple it with research institute and pharmaceutical company partners to generate new drugs. One example of a network led by the BMGF is the TB Drug Accelerator in which Pharma companies and leading TB researchers collaborate together to deliver drug candidates. This will be described in more detail as an example of what can be achieved when world leading disease knowledge and biology is coupled with excellence in drug discovery.

Partnering with pharma to impact neglected diseases around the world

254th National Meeting (2017)

The official archive and repository for all ACS Meetings & Expositions abstracts and select posters or presentations.